| 000 | 01465 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250512005211.0 | ||
| 264 | 0 | _c19891018 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0143-4179 | ||
| 024 | 7 |
_a10.1016/0143-4179(89)90032-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuito, F L | |
| 245 | 0 | 0 |
_aJejunal proabsorptive actions of selective opiate agonists administered via the cerebral ventricles. _h[electronic resource] |
| 260 |
_bNeuropeptides _cJul 1989 |
||
| 300 |
_a39-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
| 650 | 0 | 4 |
_aAlprostadil _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Water _xmetabolism |
| 650 | 0 | 4 | _aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- |
| 650 | 0 | 4 | _aEnkephalin, D-Penicillamine (2,5)- |
| 650 | 0 | 4 |
_aEnkephalins _xpharmacology |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 |
_aJejunum _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReceptors, Opioid _xmetabolism |
| 700 | 1 | _aBrown, D R | |
| 773 | 0 |
_tNeuropeptides _gvol. 14 _gno. 1 _gp. 39-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0143-4179(89)90032-2 _zAvailable from publisher's website |
| 999 |
_c2556798 _d2556798 |
||